| ISA | BIOLOGICAL-RESPONSE-MODIFIER |
| ANCESTORS | ALL ANTINEOPLASTIC-AGENT BIOLOGICAL-RESPONSE-MODIFIER DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| levamisole | definition: drug used in adjuvant chemotherapy, which stimulates the body's immune system. It is used in combination with 5-FU as treatment for colorectal cancer. Possible side effects are nausea, vomiting and diarrhea, skin rashes, and infrequent and temporary bone marrow damage. It is taken orally. (en) number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): i_levami.txt origination date: 04/06/2002 |
| LEV | definition: see levamisole (en) number: mass part of speech: noun reliability code: 10 term type: acronym |
| Ergamisol | definition: see levamisole (en) number: mass part of speech: noun reliability code: 10 term type: synonym |
| levamisol | definition: fármaco utilizado en quimioterapia adyuvante en combinación con 5-FU para combatir el cáncer colorrectal. Se cree que estimula o aumenta la actividad del sistema inmunológico. Efectos secundarios incluyen nauseas, vómitos y diarrea, erupciones cutáneas y, con menos frecuencia, alteraciones medulares. Administración oral. (es) gender: masculine number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): e_levami.txt origination date: 03/06/2002 |